Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Self-help Lifestyle Medicine App and Booklets for Depression

2 novembre 2021 aggiornato da: Fiona YY Ho, Chinese University of Hong Kong

A Comparison of Self-help Lifestyle Modification Delivered by a Smartphone App and Booklets in Managing Depressive Symptoms: a Pilot Randomised Controlled Trial.

This study aims to compare self-help lifestyle medicine (LM) delivered by a smartphone app and booklets in managing depressive symptoms in a Chinese population.

This study is a randomised controlled trial. First, informed consent will be obtained from potential participants. Around 90 eligible participants will be randomly assigned to either the LM app group, the LM booklet group, and the waitlist control group, in a ratio of 1:1:1. The app group will receive an app to facilitate lifestyle modification such as video demonstrations of physical activity, diet recommendations, stress and sleep management. The booklet group will receive 8 LM booklets with identical content with the LM app. The waitlist control group will receive access to the app and booklets at the end of the study. The whole intervention lasts 8 weeks. Participants will also receive 2 messages per week from the researcher to check and prompt motivation and adherence. Participants will complete assessment before, immediately after intervention, at one month and 12-week follow up.

Panoramica dello studio

Descrizione dettagliata

As lifestyle plays an important role in the pathogenesis of depression, lifestyle medicine (LM) emerges as a new way to alleviate depressive symptoms (Sarris & O'Neil, 2016). Booklets have been shown as an inexpensive and effective delivery modality of lifestyle modification among individuals with physical conditions (Wong, Chair & Wong, 2017). Meanwhile, a recent meta-analysis supports the efficacy of mobile applications in improving depressive symptoms (Linardon, Cujipers, Carlbring, Messer & Fuller-Tyszkiewicz, 2019). Notably, the efficacy of lifestyle intervention using booklets and app have not been compared. This pilot study can inform the field about the efficacy of lifestyle intervention using two self-help delivery modalities and offer new ways to better managing depressive symptoms.

This study will be a randomised controlled trial comparing self-help LM delivered by a smartphone app and booklets in improving depression. For a pilot study, a sample size of 12 per group is recommended (Julious, 2005). Considering an estimation of 20% attrition at the three assessment time points, the final sample size is 90, with 30 participants in each group.

The LM booklet group will receive a pocket size 6-page booklet weekly that covers 8 lifestyle medicine themes including stress, relaxation, diet, exercise, sleep hygiene, worry management, mindfulness, and positive psychology. Exercises based on cognitive behavioural therapy and guidance to set and meet short term and long-term goals are featured in the booklets. The booklet series is reviewed by a panel of experts including clinical psychologists, psychiatrists, dietitians, physical trainers, and traditional Chinese Medicine practitioners. The app group will receive access to a mobile app that offers 8 modules with identical content as the wellness booklets, in addition to videos, relaxation, exercise and cooking demonstrations, daily challenges and record of goals. The waitlist control group will receive access to the app and booklets at the end of the study.

Tipo di studio

Interventistico

Iscrizione (Anticipato)

90

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Chung Yan Chow, Undergraduate
  • Numero di telefono: 39436575
  • Email: pmhlab@cuhk.edu.hk

Luoghi di studio

      • Sha Tin, Hong Kong
        • The Chinese University of Hong Kong

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Participants with elevated depressive symptoms as defined by PHQ-9 score 10 or above
  • Hong Kong residents
  • Aged 18 or above
  • Able to read Chinese and type in Chinese or English
  • Have an Internet-enabled mobile device (iOS or Android operating system)

Exclusion Criteria:

  • Pregnancy;
  • Using medication or psychotherapy for depression;
  • Currently participating in other psychological intervention studies;
  • Cognitive impairment;
  • Having unsafe conditions and are not recommended for physical activity or a change in diet by physicians;
  • Self-disclosure of any major psychiatric, medical, or neurocognitive disorders that make participation unsuitable or may interfere with the adherence of the lifestyle modification;
  • Any suicidal ideation (scoring above 2 in item 9 in BDI-II) Participants with any urgent health necessity were excluded and referred.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Lifestyle medicine smartphone app
The app group will receive an app to facilitate lifestyle modification such as video demonstrations of physical activity, diet recommendations, stress and sleep management.
The lifestyle medicine app offers 8 modules with identical content as the wellness booklets, in addition to videos, relaxation, exercise and cooking demonstrations, daily challenges, record of goals, and ecological momentary assessments of diet, physical activity, sleep, stress and mood.
Sperimentale: lifestyle medicine booklets
The booklet group will receive 8 lifestyle medicine and psychoeducation booklets with identical content with the lifestyle medicine app.
Participants will receive a pocket size 6-page booklet weekly over 8 weeks that covers 8 lifestyle medicine, mental health and CBT themes including stress, relaxation, diet, exercise, sleep hygiene, worry management, mindfulness, and positive psychology, and guides participants to set and meet short term and long-term goals.
Comparatore fittizio: waitlist control
The waitlist control group will receive access to the lifestyle medicine app and booklets at the end of the study.
The waitlist control group will receive access to the lifestyle medicine app and booklets at the end of the study.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in the Patient Health Questionnaire (PHQ-9)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).
baseline, immediately post-intervention, 4-week and 12-week follow-up

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Self-developed survey
Lasso di tempo: Baseline
A self-developed survey will collect information including demographic information (e.g., age, gender, level of education, working industry, relationship status, and location of residence), substance use, body mass index (BMI), rest-activity pattern, and social rhythms, etc.
Baseline
Change in the World Health Organization 5-item Well-Being Index
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
This is a 5-item measure of global subjective well-being. The internal consistency prior to treatment was 0.86.
baseline, immediately post-intervention, 4-week and 12-week follow-up
Change in the Short Form (Six-Dimension) Health Survey (SF-6D)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
SF-6D is a preference-based single index measure of health. A six-digit number represents each SF-6D health state, each digit denotes the level of one of six SF-6D dimensions: physical functioning, role limitation, social functioning, bodily pain, mental health, and vitality.
baseline, immediately post-intervention, 4-week and 12-week follow-up
Change in the Perceived Stress Scale (PSS)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
The PSS measures the perceived amount of stress experienced over the past month.
baseline, immediately post-intervention, 4-week and 12-week follow-up
Change in the Generalized Anxiety Disorder 7-Item Scale (GAD-7)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
The GAD-7, a 7-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of anxiety over the past two weeks on a 4-point scale, "0" (not at all) to "4" (nearly every day).
baseline, immediately post-intervention, 4-week and 12-week follow-up
Change in the Sheehan Disability Scale (SDS)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.
baseline, immediately post-intervention, 4-week and 12-week follow-up
Change in the Health-Promoting Lifestyle Profile (HPLP II)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
The 52-item HPLPII is composed of a total scale and six subscales to measure behaviors in the theorized dimensions of health-promoting lifestyle: spiritual growth, interpersonal relations, nutrition, physical activity, health responsibility, and stress management.
baseline, immediately post-intervention, 4-week and 12-week follow-up
Change in the International Physical Activities Questionnaire - Chinese version (IPAQ-C)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
Participants' sitting time, walking time and moderate and vigorous physical activity are assessed by 5 questions from the short form of the International Physical Activity Questionnaire - Chinese version. Participants' engagement in brief strength and stamina-enhancing activity were assessed by asking the number of days they engaged in physical activity while seated and standing in the last seven days.
baseline, immediately post-intervention, 4-week and 12-week follow-up
Change in the Insomnia Severity Index (ISI)
Lasso di tempo: baseline, immediately post-intervention, 4-week and 12-week follow-up
The ISI is a 7-item scale designed to evaluate perceived insomnia severity. Ratings on the 5-point Likert scale are obtained on the perceived severity of sleep-onset, sleep-maintenance, early morning awakening problems, satisfaction with current sleep pattern, interference with daily functioning, noticeably of impairment attributed to the sleep problem, and level of distress caused by the sleep problem.
baseline, immediately post-intervention, 4-week and 12-week follow-up

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Anticipato)

1 novembre 2021

Completamento primario (Anticipato)

1 agosto 2022

Completamento dello studio (Anticipato)

1 dicembre 2022

Date di iscrizione allo studio

Primo inviato

9 ottobre 2021

Primo inviato che soddisfa i criteri di controllo qualità

9 ottobre 2021

Primo Inserito (Effettivo)

21 ottobre 2021

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

3 novembre 2021

Ultimo aggiornamento inviato che soddisfa i criteri QC

2 novembre 2021

Ultimo verificato

1 novembre 2021

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • PSY017

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi